You are here

Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Chubu Rosai Hospital
Nagoya, Aichi, 455-8530 Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Heart Failure
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
55 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Japanese chronic systolic heart failure patients with LVEF = and NYHA II or more

- Patients who receive standard therapy (Angiotensin converting enzyme inhibitors,
angiotensin receptor blockers, beta-blocker or diuretic)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients with a myocardial infarction, stroke, cardiac surgery or percutaneous
coronary intervention within 30 days prior to randomization.

- Patients with serum potassium >5.0 mmol/L or eGFR

NCT01115855
Pfizer
Completed
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now